Use of calcium channel antagonists in myocardial revascularization procedures.


Journal Article (Review)

Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.

Full Text

Duke Authors

Cited Authors

  • Califf, RM; Tardiff, BE; Pieper, KS; Hillegass, WB

Published Date

  • June 20, 1996

Published In

Volume / Issue

  • 77 / 16

Start / End Page

  • 26D - 31D

PubMed ID

  • 8677894

Pubmed Central ID

  • 8677894

International Standard Serial Number (ISSN)

  • 0002-9149

Digital Object Identifier (DOI)

  • 10.1016/s0002-9149(96)00305-0


  • eng

Conference Location

  • United States